Adamas pharmaceuticals inc (ADMS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-92,176

-105,186

-110,994

-116,564

-125,686

-130,999

-131,473

-121,681

-108,433

-89,490

-75,093

-66,127

-62,258

-60,058

-55,788

-56,253

-53,428

-51,802

-31,381

-26,079

4,401

10,223

31,436

37,554

17,772

50,921

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation

1,068

1,200

1,363

1,458

1,485

1,500

1,411

1,362

1,299

1,200

1,122

1,044

947

800

691

607

502

435

362

254

203

155

122

97

77

66

0

0

0

Stock-based compensation

10,949

12,852

14,539

14,219

15,429

15,786

15,489

14,608

14,224

13,367

12,700

12,036

10,902

10,571

10,533

10,558

10,367

9,956

9,501

8,915

8,298

7,203

5,161

3,256

1,567

640

0

0

0

Accretion of interest expense

14,937

15,044

15,172

16,682

17,997

19,092

17,563

13,854

9,471

4,645

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of embedded derivative liability

-1,045

-805

-1,127

-987

-959

-882

-279

250

270

294

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in preferred stock warrant value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

983

4,436

4,866

4,870

4,526

0

0

0

Net accretion of discounts and amortization of premiums of available-for-sale securities

989

1,219

1,341

1,376

1,329

1,045

461

-183

-180

-456

-247

779

336

301

307

-1,891

-1,327

-875

0

0

0

-

-

-

-

-

-

-

-

Provision for write-down of inventory

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities
Accrued interest of available-for-sale securities

-324

-50

-471

-362

-661

-74

74

345

768

161

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

-1,751

259

260

2,999

5,885

5,144

5,273

3,378

-76

-427

-766

-826

1,228

-490

-167

499

-24

760

816

143

234

395

4

-41

-623

-761

0

0

0

Inventory

1,290

970

-1,116

2,071

2,629

3,273

6,530

3,372

2,204

1,646

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-1,246

-1,560

1,031

-562

4,860

5,036

5,444

7,745

2,908

2,036

-5,324

-4,600

-4,415

-2,643

6,348

4,991

5,283

4,416

-303

283

-32

381

633

767

48

-80

0

0

0

Operating lease right-of-use assets

-1,154

-1,008

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

0

0

4,750

-

-1,581

-514

-28

502

3,053

918

-733

-788

-249

729

3,575

1,521

1,712

-722

-2,987

-1,157

0

0

0

Current portion of long-term debt

-6,828

-6,450

-6,024

-5,431

-4,222

-2,618

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of operating lease liabilities

1,355

1,188

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29,611

0

0

0

Accrued liabilities and other liabilities

-1,979

678

831

4,633

5,326

3,484

6,170

5,803

6,959

6,378

3,219

-1,722

-1,991

-2,721

-2,782

939

1,846

-820

8,454

6,864

5,089

9,734

1,527

1,126

1,025

523

0

0

0

Net cash used in operating activities

-77,175

-80,779

-86,071

-90,647

-100,341

-104,223

-105,442

-97,590

-77,690

-66,827

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

43,813

45,535

22,951

26,801

0

0

0

Cash flows from investing activities
Purchases of property and equipment

11

18

-595

585

569

1,064

1,999

1,134

1,396

1,258

1,338

1,001

1,527

1,624

1,490

2,196

1,842

1,399

2,222

1,538

1,226

1,285

199

211

198

167

0

0

0

Purchases of available-for-sale securities

107,020

93,869

72,214

55,215

42,269

200,354

190,771

206,235

234,414

62,510

64,524

143,599

110,520

103,528

122,778

41,393

41,393

59,828

0

0

0

-

-

-

-

-

-

-

-

Maturities of available-for-sale securities

169,750

182,750

171,750

166,520

147,280

132,080

123,163

101,793

100,333

89,333

91,898

81,890

80,171

78,443

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

62,719

88,863

100,131

110,720

104,442

-69,338

-69,607

-105,576

-135,477

25,565

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-199

-211

-198

-167

0

0

0

Cash flows from financing activities
Proceeds from public offerings, net of offering costs

-

-

-

-

-

134,268

134,268

134,268

134,433

0

0

0

-208

61,822

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock upon exercise of stock options

286

310

304

1,217

2,821

3,345

9,257

10,202

9,025

9,110

3,240

2,045

3,478

2,966

0

0

0

-

0

0

0

-

246

264

54

21

0

0

0

Principal payments on convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,000

0

0

0

Proceeds from issuance of common and preferred stock upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,986

0

0

0

-

-

-

-

Net cash provided by financing activities

1,061

1,085

1,147

2,060

3,893

138,850

209,694

210,152

243,191

108,843

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-13,395

9,169

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

30,024

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

44,864

43,315

-1,513

-3,979

0

0

0

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

88,478

88,639

21,240

22,655

0

0

0

Supplemental disclosure of noncash activities
Right-of-use assets obtained in exchange for operating lease liabilities

1,490

9,056

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment in accounts payable and accrued expense

-10

0

-471

-3

-89

7

488

20

116

61

-28

-68

-201

148

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation capitalized in inventory

290

208

167

140

179

202

195

161

88

39

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock option exercise settled after period end

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment acquired through tenant improvement allowance

-

-

-

-

-

-

-

236

163

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability assumed in noncash stock transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-